BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | Jun 6 8:20 PM | CHAN LEE | Proposed Sale | 700 | $256.11 | $179.3K | — | View → |
| Jun 6, 2025 | Jun 6 8:19 PM | LAI WANG | Proposed Sale | 1,402 | $252.39 | $353.9K | — | View → |
| Jun 6, 2025 | Jun 6 8:16 PM | JOHN OYLER | Proposed Sale | 5,127 | $252.77 | $1.3M | — | View → |
| Jun 6, 2025 | Jun 6 8:13 PM | XIAOBIN WU | Proposed Sale | 1,934 | $253.15 | $489.6K | — | View → |
| Apr 14, 2025 | Apr 14 8:21 PM | XIAODONG WANG | Proposed Sale | 125,280 | $230.36 | $28.9M | — | View → |
| Apr 1, 2025 | Apr 1 8:27 PM | XIAOBIN WU | Proposed Sale | 51,921 | $272.17 | $14.1M | — | View → |
| Mar 10, 2025 | Mar 10 9:51 PM | JOHN OYLER | Proposed Sale | 41,210 | $242.67 | $10.0M | — | View → |
| Mar 10, 2025 | Mar 10 8:19 PM | JOHN OYLER | Proposed Sale | 41,210 | $242.67 | $10.0M | — | View → |
| Mar 7, 2025 | Mar 7 10:14 PM | JOHN OYLER | Proposed Sale | 58,590 | $249.13 | $14.6M | — | View → |
| Mar 6, 2025 | Mar 6 10:22 PM | JOHN OYLER | Proposed Sale | 40,109 | $259.15 | $10.4M | — | View → |
| Mar 5, 2025 | Mar 5 9:26 PM | XIAOBIN WU | Proposed Sale | 51,921 | $257.31 | $13.4M | — | View → |
| Mar 4, 2025 | Mar 4 10:07 PM | WANG INVESTMENT LLC | Proposed Sale | 8,146 | $245.53 | $2.0M | — | View → |
| Mar 3, 2025 | Mar 4 2:31 AM | HHLR Advisors, Ltd. (1) | Proposed Sale | 2,480,000 | $271.80 | $674.1M | — | View → |
| Mar 3, 2025 | Mar 3 10:30 PM | JOHN OYLER | Proposed Sale | 101,000 | $244.30 | $24.7M | — | View → |
| Feb 28, 2025 | Mar 1 2:43 AM | Baker Brothers Life Sciences, L.P. | Proposed Sale | 671,976 | $260.00 | $174.7M | — | View → |
| Feb 28, 2025 | Mar 1 2:40 AM | 667, L.P. | Proposed Sale | 60,851 | $260.00 | $15.8M | — | View → |
| Feb 27, 2025 | Feb 27 9:27 PM | CHAN LEE | Proposed Sale | 1,205 | $259.00 | $312.1K | — | View → |
| Feb 21, 2025 | Feb 21 9:24 PM | CHAN LEE | Proposed Sale | 1,202 | $244.20 | $293.5K | — | View → |
| Feb 21, 2025 | Feb 21 9:23 PM | WANG HOLDINGS LLC | Proposed Sale | 5,000 | $244.20 | $1.2M | — | View → |
| Feb 18, 2025 | Feb 18 9:29 PM | XIAOBIN WU | Proposed Sale | 51,921 | $230.86 | $12.0M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 403,364(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Option Exercise | 403,364 | — | 806,715(D) | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 1,210,079(D) | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Option Exercise | 34,658 | — | 88,582(D) | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,697 | — | 98,930(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 441,870 | — | 0(D) | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 840,164 | — | 441,870(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 2,165,761 | — | 1,282,034(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,515,241 | — | 1,254,513(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,736,800 | — | 462,866(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 630,760 | — | 1,264,666(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 152,074 | — | 1,895,426(D) | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 8,632 | — | 105,300(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
Page 1 of 2
Next →